remove_red_eye 508 Views
#Infectious Diseases #Pathology and Lab Medicine #Pediatrics #Pharmacist
Hydroxyurea treatment was feasible and safe in children with sickle cell anemia living in sub-Saharan Africa. Hydroxyurea use reduced the incidence of vaso-occlusive events, infections, malaria, transfusions, and death, which supports the need for wider access to treatment. These findings were published December 1, 2018 in the New England Journal of Medicine.
Continue reading your article with a Emedinexus account..